TRIANGLE Study: Ibrutinib vs Stem Cell Transplant in Younger Patients With MCL
Boyu Hu, MD, and Bijal D. Shah, MD, provide their thoughts on the TRIANGLE study looking at ibrutinib versus stem cell transplant in MCL.
EP: 1.Overview of Mantle Cell Lymphoma and First-Line Treatment Options
EP: 2.Patient Profile 1: A 74-Year-Old Man Diagnosed With Mantle Cell Lymphoma
Now Viewing
EP: 3.TRIANGLE Study: Ibrutinib vs Stem Cell Transplant in Younger Patients With MCL
EP: 4.Is There a Role for Response-Adapted Treatment in Mantle Cell Lymphoma?
Related Videos
View All
Related Content
